Literature DB >> 25005178

Perspectives on tuberculosis pathogenesis and discovery of anti- tubercular drugs.

Fidele Ntie-Kang, Joseph N Yong, Luc C Owono Owono, Wolfgang Sippl, Eugene Megnassan1.   

Abstract

Based on the global burden of tuberculosis and resistant strains that have recently emerged, not responding to existing therapies, it has become urgent to search for new remedies against this global human plague that has been compounded by HIV co-infection. Thus, the search for new drugs against the disease-causing agent, Mycobacterium tuberculosis (MTB), is an ongoing effort. This review discusses the state-of-the-art in anti-tuberculosis pathogenesis and anti-TB drug research, identifying some of the challenges being faced by researchers in the field and sheds light on possible ways forward, particularly in low-income countries.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005178     DOI: 10.2174/0929867321666140706144933

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A.

Authors:  Ying-Yue Bu; Hiroyuki Yamazaki; Kazuyo Ukai; Michio Namikoshi
Journal:  Mar Drugs       Date:  2014-12-17       Impact factor: 5.118

Review 2.  Exploration of marine natural resources in Indonesia and development of efficient strategies for the production of microbial halogenated metabolites.

Authors:  Hiroyuki Yamazaki
Journal:  J Nat Med       Date:  2021-08-20       Impact factor: 2.343

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.